HUMATROPEN Trademark

Trademark Overview

On Wednesday, June 2, 1999, a trademark application was filed for HUMATROPEN with the United States Patent and Trademark Office. The USPTO has given the HUMATROPEN trademark a serial number of 75719742. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, November 18, 2020. This trademark is owned by Eli Lilly and Company. The HUMATROPEN trademark is filed in the Medical Instrument Products category with the following description:

syringe for the delivery of a growth hormone medication
humatropen

General Information

Serial Number75719742
Word MarkHUMATROPEN
Filing DateWednesday, June 2, 1999
Status800 - REGISTERED AND RENEWED
Status DateWednesday, November 18, 2020
Registration Number2392338
Registration DateTuesday, October 3, 2000
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 4, 2000

Trademark Statements

Goods and Servicessyringe for the delivery of a growth hormone medication

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, August 23, 1999
Primary Code010
First Use Anywhere DateTuesday, August 24, 1999
First Use In Commerce DateTuesday, August 24, 1999

Trademark Owner History

Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Wednesday, November 18, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, November 18, 2020REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Wednesday, November 18, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, November 10, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 21, 2020TEAS SECTION 8 & 9 RECEIVED
Friday, September 24, 2010REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 24, 2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, September 23, 2010TEAS SECTION 8 & 9 RECEIVED
Saturday, October 21, 2006REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, August 24, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, August 24, 2006TEAS SECTION 8 & 15 RECEIVED
Thursday, February 16, 2006CASE FILE IN TICRS
Thursday, February 16, 2006CASE FILE IN TICRS
Monday, November 8, 2004PAPER RECEIVED
Tuesday, October 3, 2000REGISTERED-PRINCIPAL REGISTER
Wednesday, August 2, 2000ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 27, 2000ASSIGNED TO EXAMINER
Monday, July 24, 2000STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 30, 2000USE AMENDMENT FILED
Tuesday, March 28, 2000NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 4, 2000PUBLISHED FOR OPPOSITION
Friday, December 3, 1999NOTICE OF PUBLICATION
Tuesday, September 21, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 10, 1999ASSIGNED TO EXAMINER

Related Keywords

humatropen medication hormone growth delivery syringe